Organizations
Conferences
Info & Opinion
March 16, 2010
The Brazilian association of CROs helped trim the nation’s regulatory pathway. Now it is hoping for similar efficiencies in the ethical review process.
Soon, Brazil may no longer have the second-longest trial start-up time on earth.
At the recent annual meeting for regulatory affairs professionals, there were two presentations on the right attitude for China and Brazil.
News bulletins for September 8, 2007.
Brazil is one of only two Latin American countries (besides Argentina) to have its own contract research organization (CRO) association, and one of only a handful of countries on Earth to do so. That alone speaks volumes about the maturity and…
Given the attractions of Brazil, delineated in a previous article, why have large sponsors and contract research organizations (CROs) hesitated to launch projects there? Dennis Hurley, Kendle‘s president of global clinical development for Latin America, says the regulatory environment is the…
In a session about two of the most promising pharmaceutical markets (for both sales and clinical trials) the 2007 Regulatory Affairs Professionals Society conference had well-travelled speakers to a variety of countries. We happened to hear two presentations that were designed…
On September 12, 2007, Medidata Solutions, Tessella and United BioSource Corporation will deliver their third joint webinar in a series. The topic: adaptive clinical trials. The presenters are Hugh Levaux, vice president of product strategy for Medidata Solutions; Tom Parke, head…